Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics (ARCaNE)
This study has been completed.
Sponsor:
Vanderbilt University
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00831961
First received: January 28, 2009
Last updated: January 13, 2010
Last verified: January 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Show Detailed Description
Repeated exposure to topical antibiotics may alter the normal bacteria on the eye and in the nose and increase rates of resistance. This study will determine whether repeated short-term exposure to topical antibiotic drops which are commonly prescribed after eye injections to reduce the chance of infection increase rates of resistant bacteria which are normally found on the eye and in the nose.
We hypothesis that certain commercially available antibiotics may increase rates of bacteria resistance more so than others.
Condition | Intervention |
---|---|
Age-Related Macular Degeneration |
Procedure: Conjunctival and nasopharyngeal bacteria cultures |
Study Type: | Observational |
Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Official Title: | Prospective, Randomized, Observational Cohort Study of Antibiotic Resistance After Repeated Application of Topical Antibiotics |
Resource links provided by NLM:
Genetics Home Reference related topics:
age-related macular degeneration
X-linked juvenile retinoschisis
U.S. FDA Resources
Further study details as provided by Vanderbilt University:
Primary Outcome Measures:
- Establish baseline susceptibility and resistance patterns of normal conjunctival and nasopharyngeal flora of patients with choroidal neovascularization. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Monitor changes in normal conjunctival and nasopharyngeal flora after repeated exposure to topical antibiotics over a 2 year period. [ Time Frame: 2 ] [ Designated as safety issue: No ]
Estimated Enrollment: | 40 |
Study Start Date: | January 2009 |
Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Patients randomized to gatifloxacin (Zymar)
|
Procedure: Conjunctival and nasopharyngeal bacteria cultures
Conjunctival and nasopharyngeal bacteria cultures
|
2
Patients randomized to moxifloxacin (Vigamox)
|
Procedure: Conjunctival and nasopharyngeal bacteria cultures
Conjunctival and nasopharyngeal bacteria cultures
|
3
Patients randomized to ofloxacin (Ocuflox)
|
Procedure: Conjunctival and nasopharyngeal bacteria cultures
Conjunctival and nasopharyngeal bacteria cultures
|
4
Patients randomized to azithromycin (AzaSite)
|
Procedure: Conjunctival and nasopharyngeal bacteria cultures
Conjunctival and nasopharyngeal bacteria cultures
|
Show Detailed Description
Eligibility
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Study Population
Patients age greater than 18 with choroidal neovascularization with planned treatment with intravitreal injections.
Criteria
Inclusion Criteria:
- age greater than 18 with choroidal neovascularization with planned treatment with intravitreal injections
Exclusion Criteria:
- Use of topical antibiotics for any reason within 3 months, current use of systemic or topical antibiotics, known allergies to gatifloxacin, moxifloxacin, ofloxacin, and azithromycin
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00831961
Locations
United States, Tennessee | |
Vanderbilt Eye Institute | |
Nashville, Tennessee, United States, 37232 |
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: | Stephen J Kim, MD | Vanderbilt University Department of Ophthalmology |
More Information
No publications provided by Vanderbilt University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Keywords provided by Vanderbilt University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 18, 2012
No publications provided by Vanderbilt University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Stephen J. Kim, Assistant Professor in Ophthalmology, Vanderbilt University Department of Ophthalmology |
ClinicalTrials.gov Identifier: | NCT00831961 History of Changes |
Other Study ID Numbers: | 090020 |
Study First Received: | January 28, 2009 |
Last Updated: | January 13, 2010 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by Vanderbilt University:
Antibiotic resistance, Conjunctival flora, Intravitreal injections |
Additional relevant MeSH terms:
Macular Degeneration Retinal Degeneration Retinal Diseases Eye Diseases |
Anti-Bacterial Agents Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on October 18, 2012